文献速递传染病防控与疫情报告免疫规划

巴基斯坦海得拉巴疫情期间伤寒结合疫苗免疫接种后的不良事件

Adverse events following immunization with typhoid conjugate vaccine in an outbreak setting in Hyderabad, Pakistan.
PubMed 文献 · Vaccine · 2020-03-20

巴基斯坦海得拉巴2018年疫情期间对6月龄至10岁儿童开展伤寒结合疫苗接种活动,约207000名儿童接种。通过主动随访7139名儿童和199861名家长热线自报两种途径监测免疫接种后不良事件(AEFI),共观察到499例AEFI,无严重AEFI,认为该疫苗在疫情期间接种是安全的。

要点

  • 6月龄至12月龄儿童AEFI发生率0.54%,高于2至3岁儿童的0.33%(P<0.001)。
  • 发热是热线自报中最常见AEFI(38/199861=0.02%),主动随访中为206/7139=2.89%。
  • 未观察到严重AEFI,单剂Typbar-TCV在疫情期间接种是安全的。

核心结论

  • 在巴基斯坦海得拉巴疫情期间,对6月龄至10岁儿童接种单剂Typbar-TCV是安全的。

研究设计与样本

  • 在巴基斯坦海得拉巴高风险地区开展的伤寒结合疫苗(Typbar-TCV®)接种活动,对象为6月龄至10岁儿童,约207000名儿童接种。
  • 采用外展和固定中心策略,社区动员者逐户登记并动员符合条件的儿童家长。
  • 接种后观察30分钟,采用双向策略确定AEFI:为199861名家长/看护人提供24/7热线报告免疫后14天内AEFI,并对7139名儿童进行年龄分层主动随访,在第7天和第14天确定AEFI。
  • 所有AEFI由三名受训医疗官员检查,使用基于Brighton协作标准(诊断确定性3级)的结构化问卷记录,数据用Microsoft Excel Office 365分析。

主要发现

  • 共观察到499例AEFI(主动随访子集中433例,热线自报66例)。
  • 6至12月龄儿童AEFI发生率0.54%,高于2至3岁儿童的0.33%(P<0.001)。
  • 发热是热线自报中最常见AEFI(38/199861=0.02%),在主动随访14天子集中为206/7139=2.89%。
  • 局部反应性在热线自报中为10/199861(0.01%),在主动随访中为134/7139(1.88%)。
  • 未观察到严重AEFI。

关键数值与推荐

  • AEFI记录采用Brighton协作标准诊断确定性3级。
  • 6至12月龄儿童AEFI发生率0.54%,2至3岁儿童0.33%(P<0.001)。
  • 热线自报发热38/199861=0.02%,主动随访发热206/7139=2.89%。
  • 热线自报局部反应性10/199861=0.01%,主动随访局部反应性134/7139=1.88%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pakistan is facing the world's largest outbreak of extensively drug-resistant (XDR) Typhoid. Vaccination campaign for children aged 6 months to 10 years old with Typhoid Conjugate Vaccine (Typbar-TCV®) was conducted in high-risk areas of Hyderabad during 2018. About 207,000 children were vaccinated. Here we report the adverse events following immunization (AEFI) during the campaign. The campaign was carried out using outreach and fixed centre strategy. Community mobilizers visited each household to perform line listing and mobilize parents with age-eligible children. Children were observed for 30 min post-vaccination. Two-pronged strategy was used for ascertainment of AEFI. A 24/7 hotline number was provided to all parents/caretakers (n = 199,861) to report AEFI during 14 days following immunization. An age-stratified (n = 7139 children) were actively followed at days 7 and 14 for the ascertainment of AEFI. All AEFI were examined by three trained medical officers. A structured questionnaire using Brighton collaboration criteria with level 3 diagnostic certainty was used for the recording of AEFI. Data were analysed using Microsoft Excel Office 365. Overall, 499 AEFI (433 in the subset actively followed and 66 self-reported through hotline) were observed. The rate of AEFI was significantly higher among very young children (age group 6 to 12 months) as compared to 2 to 3 years old children (0.54% vs. 0.33% respectively; p-value < 0.001). Fever was the most common AEFI self-reported through the hotline (38/199,861 = 0.02%) and among the subset followed actively for 14 days (206/7139 = 2.89%). Fever was followed by local reactogenicity 10/199,861(0.01%), and 134/7139 (1.88%) through self-reported hotline and active follow-up, respectively. No serious AEFI was observed. Administration of a single dose of Typbar-TCV among children aged 6 months to 10 years old during an outbreak setting of Hyderabad Pakistan was safe.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Qamar FN, Yousafzai MT, Khaliq A, et al. Adverse events following immunization with typhoid conjugate vaccine in an outbreak setting in Hyderabad, Pakistan. Vaccine. 2020. PMID: 32201138. doi:10.1016/j.vaccine.2020.03.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。